Target intelligence / Profile preview

POU domain class 5 transcription factor 1 mRNA (POU5F1 mRNA) (POU5F1 mRNA)

Target
POU5F1 mRNA
Molecular classification
Nucleic acid, Messenger RNA
01

Overview

POU domain class 5 transcription factor 1 (POU5F1) mRNA, commonly known as OCT4 mRNA, encodes a master transcription factor that is essential for the maintenance of pluripotency and self-renewal in embryonic stem cells and primordial germ cells (UniProt, 1.2.2; GeneCards, 1.2.2). While its expression is typically silenced in adult somatic tissues, it is frequently reactivated in various malignancies, particularly in cancer stem cell (CSC) populations, where it drives tumor progression, chemoresistance, and metastasis (NIH, 1.3.2; AACR, 1.3.4). As a therapeutic target, POU5F1 mRNA is being actively explored using RNA-based strategies such as small interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs) to downregulate OCT4 protein levels and induce differentiation or apoptosis in cancer cells (Ant Bio, 1.3.1; Drug Discovery News, 1.1.1). Targeting the mRNA transcript provides a strategic advantage over direct protein inhibition, as the OCT4 protein lacks traditional small-molecule binding pockets. However, therapeutic development faces challenges related to the precise delivery of RNA molecules and the potential for adverse effects on endogenous stem cell populations required for tissue homeostasis (NIH, 1.4.3; News-Medical, 1.4.4).

Other names
Octamer-binding transcription factor 4 mRNAOCT4 mRNAOCT3 mRNAOTF3 mRNAPOU5F1 transcriptOct-3/4 mRNA
02

Mechanism of action

RNA interference (siRNA) or antisense-mediated degradation (ASO) of the mRNA transcript to prevent translation of the OCT4 protein.

03

Biological functions

Pluripotency maintenanceSelf-renewalEmbryonic developmentCell differentiationCellular reprogramming
04

Disease associations

CancerGerm cell tumorBreast cancerProstate cancerHepatocellular carcinomaCervical cancerEsophageal squamous cell carcinoma
05

Safety considerations

Off-target effects on somatic stem cellsImpairment of normal tissue regenerationPotential developmental toxicityImmunogenicity of synthetic RNADelivery challenges (e.g., LNP-associated toxicity)
06

Interacting drugs

si-OCT4 (experimental)

2 more in the full profile.

07

Biomarkers

OCT4 protein expression (IHC)POU5F1 mRNA levels (RT-qPCR)OCT4A isoform levels

Beyond the preview

Go deeper on POU domain class 5 transcription factor 1 mRNA (POU5F1 mRNA) (POU5F1 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on POU domain class 5 transcription factor 1 mRNA (POU5F1 mRNA) (POU5F1 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call